Newsletters

09.25.18

Ninth Circuit Clarifies Implied-Certification Claims Test Under the FCA

Recent Ninth Circuit case law created uncertainty about the requirements for establishing an implied false certification claim following the Supreme Court’s decision in Universal Health Services, Inc. v. United States ex rel. Escobar, 136 S. Ct. 1989 (2016).


09.25.18

Gain New Insights Into Critical Medicaid Managed Care Trends

Join Manatt Health for the Next Two Webinars in Our Medicaid Managed Care Series.


09.25.18

CMS Shifts Quality Measures From Process to Outcomes

The Medicare Hospital Value-Based Purchasing (VBP) Program marked one of the first major steps made by the Centers for Medicare & Medicaid Services (CMS) in transitioning from a volume-based payment system to one in which providers are paid based on quality.


09.25.18

New Webinar: How Can You Protect Your Organization From TCPA Litigation?

Learn the Answer at Manatt’s New Webinar, “Telephone, Texts and the TCPA: Everything Healthcare Organizations Need to Know.”


08.30.18

CMS Releases Guidance Formalizing Budget Neutrality Policies

On August 22, 2018, the Centers for Medicare & Medicaid Services (CMS) released a State Medicaid Director Letter (SMDL) memorializing its long-standing budget neutrality policies requiring that waivers under Section 1115 of the Social Security Act (1115 waivers) cost no more to the federal ...


08.21.18

Overcoming Data-Sharing Challenges in the Opioid Epidemic

It is difficult to exaggerate the impact of the opioid epidemic on the nation’s health.


08.21.18

Ransomware Attacks in Healthcare: Nine Key Questions Answered

To determine if data has been accessed or exfiltrated from its network, an organization must implement a robust logging and monitoring process.


08.21.18

Now on Demand—“Ransomware Attacks in Healthcare: Preparing and Protecting Your Organization”

Click Here to View the Webinar Free, on Demand—and Earn CLE. Click Here to Download a Free Copy of the Webinar Presentation.


08.21.18

President Trump’s Drug Pricing Plan: What’s Next?

The Administration’s drug pricing plan, “American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs,” unveiled in May included tough rhetoric for the stakeholders in the pharmaceutical industry, including manufacturers, payers, ...


08.21.18

New Webinar: “Tracking Telehealth Reimbursement Trends”

Click Here to Register Free—and Join Us on September 13 From 1:00 – 2:00 p.m. ET